Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Placebo treatment can significantly influence subjective symptoms. However, it is widely believed that response to placebo requires concealment or deception. We tested whether open-label placebo (non-deceptive and non-concealed administration) is superior to a no-treatment control with matched patient-provider interactions in the treatment of irritable bowel syndrome (IBS). METHODS: Two-group, randomized, controlled three week trial (August 2009-April 2010) conducted at a single academic center, involving 80 primarily female (70%) patients, mean age 47 ± 18 with IBS diagnosed by Rome III criteria and with a score ≥ 150 on the IBS Symptom Severity Scale (IBS-SSS). Patients were randomized to either open-label placebo pills presented as "placebo pills made of an inert substance, like sugar pills, that have been shown in clinical studies to produce significant improvement in IBS symptoms through mind-body self-healing processes" or no-treatment controls with the same quality of interaction with providers. The primary outcome was IBS Global Improvement Scale (IBS-GIS). Secondary measures were IBS Symptom Severity Scale (IBS-SSS), IBS Adequate Relief (IBS-AR) and IBS Quality of Life (IBS-QoL). FINDINGS: Open-label placebo produced significantly higher mean (±SD) global improvement scores (IBS-GIS) at both 11-day midpoint (5.2 ± 1.0 vs. 4.0 ± 1.1, p<.001) and at 21-day endpoint (5.0 ± 1.5 vs. 3.9 ± 1.3, p = .002). Significant results were also observed at both time points for reduced symptom severity (IBS-SSS, p = .008 and p = .03) and adequate relief (IBS-AR, p = .02 and p = .03); and a trend favoring open-label placebo was observed for quality of life (IBS-QoL) at the 21-day endpoint (p = .08). CONCLUSION: Placebos administered without deception may be an effective treatment for IBS. Further research is warranted in IBS, and perhaps other conditions, to elucidate whether physicians can benefit patients using placebos consistent with informed consent. TRIAL REGISTRATION: ClinicalTrials.gov NCT01010191.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The number-needed-to-treat was 11 which should be compared with 4 for ‘placebo without deception,259 7 for alosetron,260 8 for linaclotide261 and 14 for tegaserod.262”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [259]
The cited source says what the claim attributes to it.
In the citing paper
“Several trials of psychological treatments for IBS have failed to show differential effects on symptoms when using attention control conditions [32,62-64], and a recent study showed that IBS patients even respond to open-label placebo [65].”
The cited source says what the claim attributes to it.
In the citing paper
“Kaptchuk and colleagues showed that an open label inactive placebo pill produced better outcomes in IBS patients compared to no treatment13.”
From Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial (2014) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Discovery of Grounded Theory; Strategies for Qualitative Research
Glaser, B. G., Strauss, A. L., & Strutzel, E. (1968) · Nursing Research · doi:10.1097/00006199-196807000-00014 · Cited by 39,449
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Collecting and Interpreting Qualitative Materials
Denzin, N. K., & Lincoln, Y. S. (2012) · Cited by 6,094
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · cited 1×
“Participants were adults ($18 years old) meeting the Rome III criteria for IBS [17] with a score of $150 on the IBS Symptom Severity Scale (IBS-SSS).”
MethodFRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708 · cited 3×
“[18] The open-label group improved by 92 points on this measure; in addition, the improvement shown by the openlabel placebo group exceeded that shown by the no-treatment group by 46 points.”
MethodInfluentialIs the Placebo Powerless?: An Analysis of Clinical Trials Comparing Placebo with No Treatment
Hróbjartsson, A., & Gøtzsche, P. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105243442106 · Cited by 1,503
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384 · cited 1×
“[7,8] It is a chronic functional gastrointestinal disorder characterized by abdominal pain and discomfort associated with altered bowel habits.”
BackgroundBiological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Self-citation
Research works printed but not linked: 1
- Vanner SJ Depew WT Paterson WG 2004 Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome and functional dyspepsia. Gut 53 666 72 · DOI · Paper page
Cited by
Items 301–400 of 897
Understanding the Role of Substance Expectancies in Addiction
Metrik, J., & Rohsenow, D. J. (2013) · Wiley eBooks · doi:10.1002/9781118384404.ch17 · Cited by 21
Psychiatric Neuroethics: Studies in Research and Practice
Glannon, W. (2018) · doi:10.1093/med/9780198758853.001.0001 · Cited by 31
Placebo Effects and Neuromodulation: Ethical Considerations and Recommendations
Mollica, A., Greben, R., Cyr, M., Olson, J. A., & Burke, M. J. (2023) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2023.24 · Cited by 20
Keller, P.-H., Grondin, O. S., Tison, F., & Gonon, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155940 · Cited by 19
“They concluded that placebo prescription without deception might be an effective treatment [34].”
BackgroundResultInfluentialHow Psychedelic-Assisted Treatment Works in the Bayesian Brain
Villiger, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.812180 · Cited by 23
Stuhlreyer, J., Roder, C., Krug, F., Zöllner, C., Flor, H., & Klinger, R. (2022) · BMC Medicine · doi:10.1186/s12916-022-02638-0 · Cited by 26
“The results are consistent with other studies showing that additional face-to-face physician contact leads to more positive outcomes [40].”
ResultLessons to be Learned from Placebo Arms in Psychopharmacology Trials
Doering, B. K., Rief, W., & Petrie, K. J. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_15 · Cited by 19
The role of placebo in the diagnosis and treatment of functional neurologic disorders
Rommelfanger, K. S. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801772-2.00049-7 · Cited by 20
Gupta, S., Schaffer, G., & Saps, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1462699 · Cited by 21
“The study concluded that the patient–practitioner relationship augments the success of placebo therapy [71].”
BackgroundThe placebo and its effects: A psychoneuroendocrinological perspective
Gaab, J. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.08.008 · Cited by 19
Holt, R. R., Zuelch, M. L., Charoenwoodhipong, P., Al-Dashti, Y. A., Hackman, R. M., & Keen, C. L. (2020) · Food & Function · doi:10.1039/c9fo01844a · Cited by 20
Locher, C., Buergler, S., Nascimento, A. F., Kost, L., Blease, C., & Gaab, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053346 · Cited by 21
Rethinking placebo in psychiatry: the range of placebo effects
McQueen, D., Cohen, S., John‐Smith, P. S., & Rampes, H. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.112.010397 · Cited by 20
“The term ‘nocebo’ was first used by Kennedy (1961), who distinguished nocebos from placebos in terms of negative v.”
BackgroundMethodFor Placebo Effects in Medicine, Seeing Is Believing
Gollub, R. L., & Kong, J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002120 · Cited by 21
“Most recently, a small pilot clinical trial in patients with IBS demonstrated that placebo pills openly labeled as placebo led to robust clinical improvement (12).”
BackgroundUnderstanding placebo effects: Implications for nursing practice
Miller, L. R., & Miller, F. G. (2015) · Nursing Outlook · doi:10.1016/j.outlook.2015.03.002 · Cited by 24
Self-citationAccardi, M., Cleere, C., Lynn, S. J., & Kirsch, I. (2013) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2013.769087 · Cited by 17
“Katpchuk and his colleagues (Kaptchuk et al., 2010) recently found that an open label placebo condition in which experimenters informed patients that they were receiving an inert substance that would produce significant improvement in irritable bowel symptoms produced outcomes superior to a no treatment condition with…”
BackgroundSelf-citationTelling the Truth About Pain: Informed Consent and the Role of Expectation in Pain Intensity
Gligorov, N. (2018) · AJOB Neuroscience · doi:10.1080/21507740.2018.1496163 · Cited by 21
“There is evidence that open-label placebos, which are placebos openly presented as such, are effective for the treatment of some conditions, such as irritable bowel syndrome (Kaptchuk et al. 2010) and attention deficit hyperactivity syndrome (ADHD) in children (Sandler and Bodfish 2007).”
BackgroundA Functional-Cognitive Perspective on the Relation Between Conditioning and Placebo Research
Houwer, J. D. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.01.007 · Cited by 18
Bassi, G. S., Kanashiro, A., Rodrigues, G. J., Cunha, F. Q., Coimbra, N. C., & Ulloa, L. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.05.008 · Cited by 18
“Second, physiological mechanisms such as physical exercise, meditation, psychological interventions or placebo treatments can induce a low-intensity stimulation able to modulate nociception and inflammation (Ulloa and Deitch 2009; Foley and Kirschbaum, 2010; Kaptchuk et al., 2010; Kox et al., 2012, 2014; Scheef et al.…”
BackgroundAn Update on the Assessment and Management of Pediatric Abdominal Pain
Friesen, C. A., Colombo, J. M., Deacy, A. D., & Schurman, J. V. (2021) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s287719 · Cited by 21
Placebo forte: Ways to maximize unspecific treatment effects
Schneider, R., & Kühl, J. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.02.022 · Cited by 19
Petkovic, G., Charlesworth, J. E. G., Kelley, J. M., Miller, F. G., Roberts, N. W., & Howick, J. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009428 · Cited by 21
“First, the Cochrane review is not up to date (relevant studies have been conducted since).(14) 40 Second, no subgroup analysis addressing our specific question about the effects of non-deceptive placebos was included.”
BackgroundSelf-citationAnnoni, M. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.028 · Cited by 20
Chang, C. (2018) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s167031 · Cited by 20
“84 The mechanism behind the placebo effect in IBS remains to be elucidated but may involve neurological and psychological aspects, including patient expectations for symptom relief and conditioning, based on previous experiences with therapy, as well as the gut–brain axis.”
Effects of Open-Label Placebos on State Anxiety and Glucocorticoid Stress Responses
Schaefer, M., Hellmann‐Regen, J., & Enge, S. (2021) · Brain Sciences · doi:10.3390/brainsci11040508 · Cited by 18
“They were explained that placebos are inactive substances and that they contain no medications, but both deceptive as well as non-deceptive placebos may still be powerful [25].”
BackgroundReis, L. D. D., Generoso, L. P., Pereira, G. S., Barú, J. P. D. S. T., Candido, N. L., Capello, M. G. M., de Castro, R. O. M., Cardoso, E. J. R., Scoz, R. D., Ferreira, L. M. A., et al. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1343413 · Cited by 18
Analgesic Placebo Treatment Perceptions: Acceptability, Efficacy, and Knowledge
Kisaalita, N. R., & Robinson, M. E. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.06.003 · Cited by 16
Milgrom, L. R. (2012) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0391 · Cited by 19
Schattner, A. (2012) · QJM · doi:10.1093/qjmed/hcr215 · Cited by 16
"Comparable Placebo Treatment" and the Ethics of Deception
Cohen, S., & Shapiro, H. (2013) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/jht052 · Cited by 17
Placebo prescription and empathy of the physician: A cross-sectional study
Braga-Simões, J., Costa, P., & Yaphe, J. (2017) · European Journal of General Practice · doi:10.1080/13814788.2017.1291625 · Cited by 16
Kisaalita, N. R., Hurley, R. W., Staud, R. M., & Robinson, M. E. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.10.017 · Cited by 17
“One study demonstrated that a placebo treatment could be delivered with limited deception and still produce clinically meaningful symptoms relief [15].”
BackgroundBody language: Its importance for communication with horses
Ladewig, J. (2018) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2018.06.042 · Cited by 16
“Although the original definition of a placebo is a simulated so-called ineffectual treatment for a disease intended to deceive the recipient, recent studies have shown that a placebo may also be effective if the patient knows he is receiving an ineffectual treatment (Kaptchuk et al., 2010).”
BackgroundCoste, J., & Montel, S. (2016) · Rheumatology · doi:10.1093/rheumatology/kew274 · Cited by 17
Optimizing Expectations via Mobile Apps: A New Approach for Examining and Enhancing Placebo Effects
Gruszka, P., Burger, C., & Jensen, M. P. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00365 · Cited by 15
“Although innovative placebo interventions [e.g., open-label placebos (61, 62)] have been tested in recent years, identical replications of these studies are lacking.”
BackgroundSommermeyer, H., Chmielowiec, K., Bernatek, M., Olszewski, P., Kopczyński, J., & Piątek, J. (2024) · Nutrients · doi:10.3390/nu16101503 · Cited by 21
“…contacts with patients and intensive caretaking during clinical IBS trials have been considered as factors that might result in high placebo effects, as they might provide patients with a form of psychological support, resulting in positive effects even in patients treated with a placebo [36,47].”
BackgroundCoaches' attitudes towards placebo interventions in sport
Szabó, A., & Müller, A. (2015) · European Journal of Sport Science · doi:10.1080/17461391.2015.1019572 · Cited by 16
“Kaptchuk et al. (2010) have shown that patients who were aware that they receive a placebo treatment still reported a better prognosis than no-treatment controls.”
BackgroundEthical Aspects of Clinical Placebo Use: What do Laypeople Think?
Köteles, F. G., & Ferentzi, E. (2012) · Evaluation & the Health Professions · doi:10.1177/0163278712453993 · Cited by 15
“Surprisingly, we have some evidence (although not conclusive) suggesting that placebo therapy without deception can also be successful (Aulas & Rosner, 2003; Kaptchuk et al., 2010; Sandler & Bodfish, 2008).”
BackgroundKaas, B. M., Humbyrd, C. J., & Pantelyat, A. Y. (2018) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12641 · Cited by 19
“Similar results were achieved for a randomized study of OLP in irritable bowel syndrome.(80) In fact, a recent meta-analysis of five trials in 260 patients with various conditions (including the two previously mentioned studies) examining OLP compared with no treatment showed a positive effect for OLP therapy, with a…”
ResultStaiano-Ross, K. (2011) · Biosemiotics · doi:10.1007/s12304-011-9112-6 · Cited by 15
Yue, Y., & Collaku, A. (2017) · Pain Medicine · doi:10.1093/pm/pnx157 · Cited by 17
Lanier, W. L., & Rajkumar, S. V. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.08.005 · Cited by 15
Colloca, L. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.04.001 · Cited by 17
No open-label placebo effect in insomnia? Lessons learned from an experimental trial
Haas, J. W., Winkler, A., Rheker, J., Doering, B. K., & Rief, W. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.110923 · Cited by 13
Pan, Y., Frank, M. L., Kaptchuk, T. J., & Nestoriuc, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276499 · Cited by 16
“In 2010, this belief of required “patient ignorance” was challenged by a landmark RCT demonstrating that improvement could be evoked even if patients were honestly informed about the pills’ lack of active substance [10].”
BackgroundSelf-citationWhat Placebos Teach Us about Health and Care: A Philosopher Pops a Pill
Ho, D. (2023) · Cambridge University Press eBooks · doi:10.1017/9781009085496 · Cited by 14
Is placebo useful in the treatment of major depression in clinical practice?
Marchesi, C., Panfilis, C. D., Tonna, M., & Ossola, P. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s44519 · Cited by 16
“Neuropsychiatric Disease and Treatment 2013:9 strategy to overcome this barrier has been proposed but not as yet tested in depressed patients.(51) However, clinicians should learn from the “placebo lesson” that expectation is a relevant mechanism that should be utilized and optimized in clinical practice, given that t…”
Explaining placebo effects in an online survey study: Does ‘Pavlov’ ring a bell?
Smits, R. M., Veldhuijzen, D. S., Hartman, T. O., Peerdeman, K. J., van Vliet, L. M., van Middendorp, H., Rippe, R. C. A., Wulffraat, N. M., & Evers, A. W. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247103 · Cited by 16
“For the integration of placebos in treatment, different methods of placebo use from previous literature were presented, for example as ‘dose extenders’ (“I think placebo treatment is acceptable when prescribed after a long period of medication”) or ‘therapeutic boosters’ (“I think placebo treatment is acceptable when…”
BackgroundMethodNeurofeedback as placebo: a case of unintentional deception?
Kalokairinou, L., Sullivan, L. S., & Wexler, A. (2021) · Journal of Medical Ethics · doi:10.1136/medethics-2021-107435 · Cited by 21
Why medication in involuntary treatment may be less effective: The placebo/nocebo effect
Meynen, G., & Swaab, D. F. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.08.029 · Cited by 14
“observed that placebos administered without deception were still effective [20].”
BackgroundResearch gaps in the philosophy of evidence‐based medicine
Mebius, A., Kennedy, A. G., & Howick, J. (2016) · Philosophy Compass · doi:10.1111/phc3.12352 · Cited by 22
Novel designs and paradigms to study the placebo response in gastroenterology
Enck, P., Chae, Y., & Elsenbruch, S. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.10.003 · Cited by 15
Physical, Logical, and Mental Top-Down Effects
Ellis, G., & Gabriel, M. (2021) · Synthese Library/Synthese library · doi:10.1007/978-3-030-71899-2_1 · Cited by 16
Placebos as a Source of Agency: Evidence and Implications
Friesen, P. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00721 · Cited by 20
The role of positive information provision in open‐label placebo effects
Barnes, K., Babbage, E., Barker, J. M., Jain, N., & Faasse, K. (2023) · Applied Psychology Health and Well-Being · doi:10.1111/aphw.12444 · Cited by 12
Winkler, A., Hahn, A., & Hermann, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-32942-5 · Cited by 12
Schaefer, M., Zimmermann, K., & Enck, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-34790-9 · Cited by 12
The self-fulfilling prophecy in medicine
Mertens, M. (2024) · Metamedicine · doi:10.1007/s11017-024-09677-z · Cited by 14
“Granting credibility to the prediction that a sugar-pill may have a curing effect [5], can be a combination of theoretical, agreeable, and employment-depend-ent credibility.”
BackgroundWhat is “clinical data”? Why and how can they be collected during field surveys on medicinal plants?
Graz, B. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.08.036 · Cited by 13
Placebo effects: a new paradigm and relevance to psychiatry
McQueen, D., & Smith, P. S. J. (2012) · International Psychiatry · doi:10.1192/s1749367600002861 · Cited by 13
Marlicz, W., Skonieczna‐Żydecka, K., Krynicka, P., Łoniewski, I., & Rydzewska, G. M. (2021) · Gastroenterology Review · doi:10.5114/pg.2021.111766 · Cited by 21
“Many patients initially benefit from placebo effect [7, 8] but respond poorly to longer-term treatments [9], either do not tolerate or not respond to pharmacotherapy, and may be worried by potential adverse events [10].”
BackgroundMethodRemotely Provided Open-Label Placebo Reduces Frequency of and Impairment by Allergic Symptoms
Κube, T., Kirsch, I., Glombiewski, J. A., Witthöft, M., & Bräscher, A. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001110 · Cited by 13
“Similar to other OLP studies (9,25), the study was labeled as a novel mind-body approach for allergic rhinitis using placebos.”
BackgroundResultSelf-citationExpectancy Effect in Three Mind-Body Clinical Trials
Hicks, M., Hanes, D. A., & Wahbeh, H. (2016) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587216652572 · Cited by 17
Public Attitudes on the Ethics of Deceptively Planting False Memories to Motivate Healthy Behavior
Nash, R. A., Berkowitz, S. R., & Roche, S. (2016) · Applied Cognitive Psychology · doi:10.1002/acp.3274 · Cited by 17
“…of this assumption is an open question, especially when we consider the results from randomized medical trials in which patients saw health improvements despite being truthfully informed that they were only receiving an inert placebo (see Kaptchuk et al., 2010, for a striking example).”
BackgroundThe placebo effect in psychiatric practice.
Bernstein, M. H., & Brown, W. A. (2017) · PubMed · Cited by 15
Clinical Role-Play in Autonomous Sensory Meridian Response (ASMR) Videos
Ahuja, A., & Ahuja, N. K. (2019) · JAMA · doi:10.1001/jama.2019.2302 · Cited by 13
Chen, Y., Bassi, G. S., & Yang, Y. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/6283912 · Cited by 19
“is effect may be partially explained by treatment expectation, as the expectation of needling can produce a larger placebo effect than acknowledging that no needling technique will be used [97, 98].”
BackgroundNeural effects of placebo analgesia in fibromyalgia patients and healthy individuals
Frangos, E., Čeko, M., Wang, B., Richards, E. A., Gracely, J. L., Colloca, L., Schweinhardt, P., & Bushnell, M. C. (2020) · Pain · doi:10.1097/j.pain.0000000000002064 · Cited by 14
“This served to reinforce the verbal suggestion that the placebo cream was an effective analgesic cream and to create conditioning independent of suggestions, which is also known to produce placebo analgesia without explicit manipulations of expectations of pain relief.(1,5,23) Two runs were conducted in themock scanne…”
BackgroundPlacebos in clinical practice: an ethical overview
Annoni, M., & Miller, F. G. (2014) · Douleur et Analgésie · doi:10.1007/s11724-014-0400-1 · Cited by 16
Self-citationEfficacy of open‐label counterconditioning for reducing nocebo effects on pressure pain
Meijer, S., Karacaoglu, M., van Middendorp, H., Veldhuijzen, D. S., Jensen, K. B., Peerdeman, K. J., & Evers, A. W. M. (2023) · European Journal of Pain · doi:10.1002/ejp.2112 · Cited by 15
Niazi, S. K. (2024) · Healthcare · doi:10.3390/healthcare12222314 · Cited by 19
Can an Educational Handout Enhance Placebo Analgesia for Experimentally-Induced Pain?
Tang, C. W., & Colagiuri, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077544 · Cited by 12
“Perhaps most interestingly, open placebo treatment, that is, when participants know they are receiving nothing more than a sugar pill, has been found to improve symptoms of both irritable bowel syndrome [10] and major depressive disorder [11].”
BackgroundDoes the word “placebo” evoke a placebo response?
Bennett, G. J. (2018) · Pain · doi:10.1097/j.pain.0000000000001269 · Cited by 13
Pain, placebo, and cognitive penetration
Shevlin, H., & Friesen, P. (2020) · Mind & Language · doi:10.1111/mila.12292 · Cited by 31
Can placebos reduce intrusive memories?
Κube, T., Kirsch, I., Glombiewski, J. A., & Herzog, P. (2022) · Behaviour Research and Therapy · doi:10.1016/j.brat.2022.104197 · Cited by 12
Self-citationDiagnostic Stringency and Healthcare Needs in Patients with Biliary Dyskinesia
Aggarwal, N., & Bielefeldt, K. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2719-5 · Cited by 13
The role of placebo effects in immune-related conditions: mechanisms and clinical considerations
Smits, R. M., Veldhuijzen, D. S., Wulffraat, N. M., & Evers, A. W. M. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1516144 · Cited by 18
“treatment expectations (open-label studies), it was demonstrated that placebo’s can still cause adequate relief [39].”
BackgroundPlacebo Economics: A Systematic Review About the Economic Potential of Utilizing the Placebo Effect
Hamberger, J., Meißner, K., Hinterberger, T., Loew, T. H., & Weimer, K. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00653 · Cited by 14
Ratnapalan, M., Coghlan, B., Tan, M., Everitt, H., Geraghty, A. W. A., Little, P. S., Lewith, G. T., & Bishop, F. L. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032524 · Cited by 13
Subjunctive medicine: A manifesto
Hardman, D. I., & Ongaro, G. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113039 · Cited by 15
Bandak, E., Overgaard, A., Kristensen, L. E., Ellegaard, K., Guldberg–Møller, J., Bartholdy, C. R., Hunter, D. J., Altman, R. D., Christensen, R., Bliddal, H., et al. (2021) · Trials · doi:10.1186/s13063-020-04952-5 · Cited by 16
Schienle, A., & Unger, I. (2021) · Scientific Reports · doi:10.1038/s41598-021-92579-0 · Cited by 12
Halsey, E. J., Xing, M., & Stockley, R. (2015) · Acupuncture in Medicine · doi:10.1136/acupmed-2014-010735 · Cited by 12
Diarrhea, Constipation, and Irritable Bowel Syndrome
Wilhelm, S. M., McConachie, S. M., & Kale-Pradhan, P. B. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.ibs_overview · Cited by 12
The Necessity of Sham Controls
Prasad, V. K., & Cifu, A. S. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.07.030 · Cited by 12
Microdosing with classical psychedelics: Research trajectories and practical considerations
Wong, A., & Raz, A. (2022) · Transcultural Psychiatry · doi:10.1177/13634615221129115 · Cited by 13
“The study was non-blinded, and open label placebo studies have already shown that placebo effects occur even in the absence of deception, and can ameliorate symptoms of irritable bowel syndrome and chronic lower back pain (Carvalho et al., 2015; Kaptchuk et al., 2010).”
BackgroundSezer, D., Locher, C., & Gaab, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-25446-1 · Cited by 9
Matthiesen, S. T., Sieg, M., Andersen, S. S., Amanzio, M., Finnerup, N. B., Jensen, T. S., Gottrup, H., & Vase, L. (2023) · Pain · doi:10.1097/j.pain.0000000000003035 · Cited by 10
A discursive exploration of public perspectives on placebos and their effects
Hardman, D. I., Geraghty, A. W. A., Howick, J., Roberts, N. W., & Bishop, F. L. (2019) · Health Psychology Open · doi:10.1177/2055102919832313 · Cited by 13
“This view reflects a trend in placebo studies research focussed on ‘open-label’ placebo treatment, purportedly bypassing the issue of deception (Carvalho et al., 2016; Colloca and Howick, 2018; Kaptchuk et al., 2010; Kaptchuk and Miller, 2018; Sandler et al., 2010).”
BackgroundTowards an account of the placebo effect: a critical evaluation alongside current evidence
Friesen, P. (2020) · Biology & Philosophy · doi:10.1007/s10539-019-9733-8 · Cited by 13
Naik, T. D., Tubaki, B. R., & Patankar, D. S. (2022) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2022.100592 · Cited by 20
Failure of Placebo Analgesia Model in Rats with Inflammatory Pain
Yin, X., Yang, J., Cao, S., & Wang, Y. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00420-6 · Cited by 13
Enfermedad celíaca y sensibilidad al gluten no celíaca
Rodrigo, L., & Peña, A. S. (2013) · doi:10.3926/oms.16 · Cited by 12
“Recientemente se ha demostrado en pacientes con el síndrome del intestno irritable la posibilidad de estudiar el efecto placebo aún a sabiendas que el medicamento consista en una sustancia inerte: “Placebo sin engaños”.(35,36) Los pacientes que tomaron placebo mostraron una mejoría de sus síntomas muy superior a quien…”
BackgroundSuprapubic Tube After Radical Prostatectomy
Prasad, S. M., Smith, N. D., Catàlona, W. J., Sammon, J. D., & Menon, M. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.03.031 · Cited by 11
Placebo: the lie that comes true?
Justman, S. (2012) · Journal of Medical Ethics · doi:10.1136/medethics-2012-101057 · Cited by 13
Managing irritable bowel syndrome: The impact of micro-physiotherapy
Grosjean, D., Benini, P., & Carayon, P. (2017) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2015-0044 · Cited by 13
Antipruritic Placebo Effects by Conditioning H1-antihistamine
Meeuwis, S. H., van Middendorp, H., Pacheco‐López, G., Ninaber, M. K., Lavrijsen, A. P. M., van der Wee, N. J. A., Veldhuijzen, D. S., & Evers, A. W. M. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000743 · Cited by 12
Behrouz, R., & Benbadis, S. R. (2014) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.11.010 · Cited by 11
A Conversation with … Ted J. Kaptchuk, Expert in Placebo Effects
Leopold, S. S. (2021) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000001824 · Cited by 10
Beliefs About Medicines Predict Side-Effects of Placebo Modafinil
Heller, M. K., Chapman, S., & Horne, R. (2022) · Annals of Behavioral Medicine · doi:10.1093/abm/kaab112 · Cited by 7
“the placebo effect is powerful (78) as we wanted to minimze both positive and negative expectations in this control group and ensure that our manipulation more closely resembled the”
Background
Metadata
- Authors
- Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- National Institutes of Health (US)
- University of Hull (GB)
- Corresponding author
- Kaptchuk, Ted J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-22
- Volume
- 5
- Issue
- 12
- Pages
- e15591
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3008733
- OpenAlex
- W2105330971
- Semantic Scholar
- 3d8aac4fba0e556c2d0898ad83cd3df11576e90c
- Cited by
- 900
- References
- 43
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 48 · 2023: 56 · 2022: 55 · 2021: 67 · 2020: 72 · 2019: 55 · 2018: 97 · 2017: 48 · 2016: 55 · 2015: 55 · 2014: 65 · 2013: 48 · 2012: 58
- FWCI
- 29.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Health and Human Services
- Bernard Osher Foundation
- National Institutes of Health (5r01at000402-04)
- Japan Society for the Promotion of Science (13J11021)
- National Center for Complementary and Alternative Medicine
- National Center for Complementary and Integrative Health (R01AT004662, K24AT004095, R01 AT00402-01)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Complementary and alternative medicine › Acupuncture Treatment Research Studies
- Keywords
- irritable bowel syndrome, placebo effect, open-label placebo, symptom severity, quality of life, patient-provider interaction, informed consent
- MeSH terms
- Adult, Female, Humans, Deception, Male, Middle Aged, Placebos, Time Factors, Treatment Outcome, Patient Satisfaction, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

